Signal2026-07-15
ClinicalTrials.gov

[PHASE4] Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

Part of

Cancer Immunotherapy And Combination Strategies

Open primary sourceSee the whole picture